Clinical trial

Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic…

NCT00003829 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00003829
Title Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
Official title A Phase II Study of Alternating Cycles of Fludarabine and Cyclophosphamide in Previously Untreated Patients With B-cell CLL
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Leukemia
Intervention type Drug
Interventions cyclophosphamide, fludarabine phosphate
Enrollment 34
Start date Aug 1, 1999
Primary completion May 1, 2001
Completion Oct 1, 2008
First posted Jun 16, 2004
Last update posted Dec 7, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies